
Sheppard, Mullin, Richter & Hampton LLP
A Limited Liability Partnership including Professional Corporations
Washington, District of Columbia Office View all offices
Eleventh Floor East, 1300 I Street, NW Washington, District of Columbia
20005-3314
Telephone: 202-218-0000 Telecopier: 202-218-0020 http://www.sheppardmullin.com
Profile Visibility  | | #263 in weekly profile views out of 2,178 law firms in Washington, District of Columbia | | #53 in weekly profile views out of 203,342 total law firms Overall |
|
| |
|
About this office:
Sheppard, Mullin, Richter & Hampton's founding partners began the firm in Los Angeles in 1927 with the simple blueprint of providing superior client service and legal counseling. Sheppard Mullin attorneys continue to respond rapidly to ever-changing business and legal environments with creative, cost-effective and practical solutions. The firm's philosophy is to staff matters with experienced, effective, results-oriented attorneys who recognize that availability, accessibility and responsiveness to our clients is fundamental.
Specific Practice & Industry Groups Details:
Statement of Practice Summary:
General Civil Trial and Appellate Practice in all State and Federal Courts; Financial Institutions Law; Commercial Law; Banking; Bankruptcy and Financial Restructuring; Construction; Creditors' Rights; Corporate; Securities; Antitrust; Entertainment; Intellectual Property; Unfair Competition; Labor and Employment; Health Care; Pension and Employee Benefits; Federal, State and Local Taxation; Government Contracts; Real Estate; Land Use; Environmental; White Collar Criminal Defense; International Business; Administrative; Probate; Trust; Estate Planning; Aerospace and Defense.
Documents by Lawyers at this office
FDA's New Reportable Food Registry RequirementsArianna Chernove, Deborah M. Shelton, October 6, 2009
The Food and Drug Administration (FDA) recently launched its Reportable Food Registry (RFR) electronic portal. In conjunction with this launch, FDA has issued a final guidance further discussing the specific requirements.
OTC Drug and Dietary Supplement Labeling: Adverse Event Reporting InformationArianna Chernove, Deborah M. Shelton, October 6, 2009
Recently, the FDA issued its final guidance on the requirements for OTC drugs and dietary supplement labeling to include contact information for consumer reporting of a serious adverse event. This guidance builds upon requirements that were passed into law in the Dietary Supplement and...
Law Firm Affiliations: TERRALEX
(For complete biographical data on Los Angeles, San Francisco, San Diego, Del Mar Heights, Orange County, Santa Barbara and Century City, California, New York and Shanghai, China personnel, see Professional Biographies at those locations)